Total Payments
$23,385
2024 Payments
$20,751
Companies
19
Transactions
91
Medicare Patients
838
Medicare Billing
$119,638
Payment Breakdown by Category
Other$16,140 (69.0%)
Food & Beverage$4,131 (17.7%)
Consulting$1,900 (8.1%)
Travel$1,099 (4.7%)
Education$114.19 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,140 | 6 | 69.0% |
| Food and Beverage | $4,131 | 66 | 17.7% |
| Consulting Fee | $1,900 | 3 | 8.1% |
| Travel and Lodging | $1,099 | 10 | 4.7% |
| Education | $114.19 | 6 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $9,555 | 17 | $0 (2024) |
| Merck Sharp & Dohme LLC | $7,618 | 15 | $0 (2024) |
| Abbott Laboratories | $2,820 | 26 | $0 (2024) |
| Merit Medical Systems Inc | $1,700 | 2 | $0 (2024) |
| ABIOMED | $828.47 | 7 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $237.25 | 4 | $0 (2024) |
| Amgen Inc. | $136.36 | 2 | $0 (2024) |
| HEARTFLOW, INC. | $123.79 | 1 | $0 (2024) |
| United Therapeutics Corporation | $81.17 | 4 | $0 (2024) |
| CVRx, Inc. | $60.51 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,751 | 60 | Actelion Pharmaceuticals US, Inc. ($9,437) |
| 2023 | $1,904 | 18 | Abbott Laboratories ($1,508) |
| 2021 | $7.50 | 3 | United Therapeutics Corporation ($7.50) |
| 2020 | $185.24 | 2 | Abbott Laboratories ($185.24) |
| 2019 | $329.12 | 3 | Abbott Laboratories ($182.51) |
| 2018 | $136.92 | 1 | Abbott Laboratories ($136.92) |
| 2017 | $70.56 | 4 | Actelion Pharmaceuticals US, Inc. ($33.45) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 4 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $175.30 | General |
| Category: Heart Failure | ||||||
| 07/11/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $102.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/06/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $4.46 | General |
| 07/01/2021 | United Therapeutics Corporation | TYVASO (Drug) | Education | In-kind items and services | $2.50 | General |
| Category: PAH | ||||||
| 02/24/2021 | United Therapeutics Corporation | TYVASO (Drug) | Education | In-kind items and services | $2.50 | General |
| Category: PAH | ||||||
| 02/24/2021 | United Therapeutics Corporation | — | Education | In-kind items and services | $2.50 | General |
| 10/27/2020 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/11/2020 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Food and Beverage | In-kind items and services | $182.51 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 12/18/2019 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Food and Beverage | In-kind items and services | $182.51 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/14/2019 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $2.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2019 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $144.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/26/2018 | Abbott Laboratories | HeartMate (Device) | Food and Beverage | In-kind items and services | $136.92 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/03/2017 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $33.45 | General |
| 05/02/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/10/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/24/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.06 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 335 | 612 | $144,882 | $49,512 |
| 2022 | 8 | 252 | 427 | $112,404 | $33,978 |
| 2021 | 8 | 251 | 443 | $118,970 | $36,147 |
Total Patients
838
Total Services
1,482
Medicare Billing
$119,638
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 39 | 110 | $25,130 | $9,942 | 39.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 102 | 149 | $29,782 | $9,860 | 33.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 21 | 56 | $29,008 | $8,965 | 30.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 58 | 137 | $22,182 | $8,178 | 36.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 36 | $14,304 | $4,618 | 32.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 19 | 22 | $5,920 | $2,269 | 38.3% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 24 | 24 | $8,428 | $2,135 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 19 | $3,838 | $1,806 | 47.1% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 23 | 59 | $6,290 | $1,737 | 27.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 46 | 154 | $39,886 | $12,113 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 65 | 100 | $19,412 | $7,389 | 38.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 41 | 48 | $12,552 | $5,258 | 41.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 34 | 50 | $9,000 | $2,795 | 31.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 17 | $8,500 | $2,311 | 27.2% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2022 | 23 | 26 | $16,458 | $2,113 | 12.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 17 | 17 | $4,403 | $1,259 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 12 | 15 | $2,193 | $739.72 | 33.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 45 | 155 | $40,145 | $12,522 | 31.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 63 | 99 | $19,394 | $7,210 | 37.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 45 | 59 | $15,500 | $6,481 | 41.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 21 | 22 | $11,000 | $2,996 | 27.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 26 | 42 | $7,560 | $2,361 | 31.2% |
| 93451 | Insertion of catheter for diagnostic evaluation of right heart structures | Facility | 2021 | 18 | 28 | $17,724 | $2,069 | 11.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 18 | 19 | $4,921 | $1,551 | 31.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 15 | 19 | $2,726 | $956.12 | 35.1% |
About Jessica Huston
Jessica Huston is a Cardiovascular Disease healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1073874616.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jessica Huston has received a total of $23,385 in payments from pharmaceutical and medical device companies, with $20,751 received in 2024. These payments were reported across 91 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($16,140).
As a Medicare-enrolled provider, Huston has provided services to 838 Medicare beneficiaries, totaling 1,482 services with total Medicare billing of $119,638. Data is available for 3 years (2021–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Advanced Heart Failure and Transplant Cardiology
- Location Nashville, TN
- Active Since 05/30/2012
- Last Updated 08/16/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1073874616
Products in Payments
- UPTRAVI (Drug) $9,420
- WINREVAIR (Biological) $7,598
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $2,279
- Impella (Device) $828.47
- HeartMate 3 Left Ventricular Dev (Device) $365.02
- Adempas (Drug) $218.53
- HeartMate (Device) $136.92
- Repatha (Biological) $136.36
- FFRct (Device) $123.79
- OPSUMIT (Drug) $101.79
- Barostim Neo System (Device) $60.51
- CARDIOMEMS (Device) $35.79
- LIVTENCITY (Drug) $33.42
- AccuCinch (Device) $24.38
- LEQVIO (Drug) $20.07
- AMVUTTRA (Drug) $19.01
- Kerendia (Drug) $18.72
- Arcalyst (Drug) $18.47
- LifeVest (Device) $14.06
- Aquadex Smartflow Console (Device) $13.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Nashville
Stephen Fahrig, Md, MD
Cardiovascular Disease — Payments: $679,196
Cardiovascular Disease $679,196
Dr. Gregory Bashian, M.d, M.D
Cardiovascular Disease — Payments: $485,755
Cardiovascular Disease $485,755
Dr. Hal Roseman, M.d, M.D
Cardiovascular Disease — Payments: $472,447
Cardiovascular Disease $472,447
Dr. Jimmy Kerrigan, Md, MD
Cardiovascular Disease — Payments: $414,382
Cardiovascular Disease $414,382
Dr. Colin Barker, M.d, M.D
Cardiovascular Disease — Payments: $393,788
Cardiovascular Disease $393,788
Joshua Beckman, Md, MD
Cardiovascular Disease — Payments: $201,658
Cardiovascular Disease $201,658